8bql

8bql Election victories for Donald Trump and other candidates whose campaigns demeaned transgender people reinforced a widespread backlash against trans rights. For America’s LGBTQ-rights movement, it adds up to one of the most sustained setbacks in its history. For transgender Americans, it’s personal: There is palpable fear of potential Trump administration steps to further marginalize them. But there is also a spirit of resilience — a determination to persevere in seeking acceptance and understanding. “I just went through an election where I couldn’t watch a sports event on TV without seeing a commercial where trans people were portrayed as monsters,” said Jennifer Finney Boylan, a transgender author who teaches at Barnard College in New York. “This hurts more than any other moment I can remember. We’ve been knocked down before. We’ll be knocked down again. All we can do is fight.” Anti-trans momentum has been growing for several years, with Republican-governed states enacting dozens of laws restricting trans people’s options for medical care, sports participation and public restroom access. Activists fear the movement will grow, with the Trump administration taking power as many Americans question the trans-rights agenda. Overall, 55% of voters — and 85% of Trump backers — said support for transgender rights in government and society has gone too far, according to AP VoteCast, a survey of more than 120,000 people who cast ballots nationwide. “There is an urgent need to show the American people the reality of transgender lives — the ordinary people for whom being trans is not the center of their lives,” said Shannon Minter, a transgender civil rights lawyer with the National Center for Lesbian Rights. “This is a frightening moment for transgender people and their families. There is a very real possibility that the new administration may adopt policies that cause them devastating harm.” Trump won the presidential contest over Vice President Kamala Harris after a campaign that included pervasive TV advertising mocking her support for trans rights. “Kamala is for they/them,” an ad that ran over 15,000 times asserted. “President Trump is for you.” Other Democratic candidates also were targeted with anti-trans ads. On an array of issues, Trump — and other Republicans who now hold majorities in both the House and Senate — have threatened to roll back protections and civil liberties for trans people. Education: Trump has pledged to impose wide-ranging restrictions on transgender students. His administration could swiftly move to exclude them from Title IX protections, which affect school policies on students’ use of preferred pronouns, bathrooms and locker rooms. Health care: At least 26 states have adopted laws restricting or banning gender-affirming medical care for trans minors. In Texas, Attorney General Ken Paxton is filing civil lawsuits against doctors he alleges were prescribing such treatments. Trump says any doctor or hospital providing gender-affirming care should be barred from Medicaid and Medicare. Sports: Trump and other Republicans embraced the anti-trans mantra opposing “boys in girls’ sports.” At least 24 states already have laws on the books barring trans women and girls from participating in certain women’s or girls’ sports competitions. In March, 16 college athletes filed a lawsuit against the NCAA, accusing it of violating their Title IX rights by allowing transgender woman Lia Thomas to compete at the 2022 national championships, where she won the 500-yard freestyle. Military: Trans-rights activists worry that Trump may reimpose a ban on trans people serving openly in the military or — as an alternative — bar any future recruiting of trans people and curtail the availability of gender-affirming medical care for service members and veterans. Trans-rights organizations are calling for coalition-building and renewed efforts to increase public understanding. They celebrated some notable victories. Sarah McBride won Delaware’s lone seat in the House of Representatives to become the first openly trans person elected to Congress. In Montana, transgender state Rep. Zooey Zephyr won reelection and will be able to return to the House floor nearly two years after she was silenced and sanctioned by her Republican colleagues. But nationwide, anger and anxiety were dominant emotions among trans activists. “This election season has been brutal,” the leaders of Advocates for Transgender Equality wrote to their supporters. “Trump targeted trans people since his campaign launch. He targeted our existence. He targeted our rights. He promised he would continue to target trans people if he won — and we know he will keep his promise.” Shelby Chestnut, executive director of the Transgender Law Center, said trans people “have become the pawn for political groups that don’t understand our communities.” “It’s a very precarious time,” Chestnut said. “We will get through this, but we have to step up and support each other. ... How do we see the long game, not just the immediate narrow view? Because it is very daunting right now. Where do we want to be in 15 years?” Public opinion on trans rights issues isn’t uniform. According to AP VoteCast, slightly more than half of voters in the 2024 election strongly or somewhat opposed laws that ban gender-affirming medical treatment, such as puberty blockers and hormone therapy, for minors. Slightly less than half of voters somewhat or strongly favored them. And according to a Gallup poll conducted last year, 69% of Americans say transgender athletes should be allowed to compete only on sports teams that conform with their birth gender. Over the past 25 years, arguably the most daunting previous phase of the LGBTQ-rights movement started in 2004, after Massachusetts became the first state to legalize same-sex marriage. Between 2004 and 2008, voters in 26 states approved ballot measures defining marriage as between one man and one woman — in effect outlawing same-sex marriage. By 2012, however, public opinion was swinging in favor of same-sex marriage. The Supreme Court legalized it nationwide in 2015, and it has had the support of most Americans ever since. Boylan recalled how that long-bitter debate tilted in favor of legalization when supporters of same-sex marriage popularized the phrase “Love is love.” “That opened doors and opened hearts,” Boylan said. “The challenge for trans people is we don’t have a phrase like that. ... The issues are more complex.” Boylan noted that the anti-trans campaign seemed to make headway with issues that are not among the core concerns of most trans people: “The primary thing we’re fighting for is not the right to play with other women on a soccer team. We’re fighting for dignity, for respect, for the right to be left alone.” Maxwell Kuzma, a transgender man working as a film editor and writer in rural Ohio, said he was “worn out” by the relentless targeting of trans people and blamed Trump for perpetuating it. Looking ahead, he said life as a trans person “has forced me to learn a resiliency that I will lean on as I continue to speak out against prejudice and discrimination.” Christine Zuba, a transgender woman from New Jersey, described a recent surge of Zoom meetings enabling trans people to express their concerns and determine next steps. “One of the best recommendations I have heard throughout this discussion is to not isolate yourself; rather surround yourself with your support group — the people you love and who love you,” she said. “Do not despair. There are a lot of people who will work with you and for you.” Get local news delivered to your inbox!By Lauren Beavis An adorable little donkey named Wonder has received a new prosthetic leg to help her stand and walk - just in time for Christmas. Wonder was born with two deformed hooves leaving her unable to stand or walk. But since being fitted with a specialist prosthesis, the young mule is now able to walk "better than ever before". At a young age, she was admitted to Donkey Sanctuary Bonaire in the Netherlands - a center for neglected, abused, confiscated, sick or old donkeys . Wonder the donkey with its new leg. ( When veterinarians at the Faculty of Veterinary Medicine at Ghent University heard about Wonder's condition, they got in touch with Wesley Michiels from Pet Orthopedics - a company that makes prostheses and braces for animals. Wesley Michiels, head of Pet Orthopedics , said: "The vets contacted us and explained that they wanted to amputate the leg - asking us how they could best go about it to ensure that the donkey would be able to walk again with a view to a prosthesis. "We were on site for about three weeks to carry out the measurements on Wonder." As the vets amputated her little hooves - the orthopedics were able to fit a prosthetic leg that grows as Wonder does. (Pet Orthopedics via SWNS) Wesley said: "The cooperation results in a perfect amputation stump so that the prosthetic device also fits perfectly. "Wonder is still a little donkey who still has to grow in the future, so the prosthesis is adaptive so we can adjust it when she grows. "In the beginning, she has to learn how to use the leg more - but with the prosthetic device she is now already walking better than before." (Pet Orthopedics via SWNS) Wesley says he has worked with donkeys before - but a full prosthesis for the species was a new task for him. He added the new technology has helped many species - from alpacas to dogs and now donkeys . Wesley said: "In the past, the legs of animals were completely amputated up to the shoulder or up to the hip for a problem with toes for example - then sometimes you couldn't do anything with one leg. "But now many vets first call us to ask for advice about the amputation, so that we can put a prosthesis afterwards."

Falcons drafting Penix no longer a head-scratcher with rookie QB shining in place of benched CousinsUnlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It’s a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It’s all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person’s response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn’t happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It’s not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn’t respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I’m hoping it’s slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.ROIC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Retail Opportunity Investments Corp. Is Fair to Shareholders

Miami (Ohio) held the Saints at bay for the duration, winning 70-58 in the semifinals of the Palms Division at the Fort Myers Tip-Off at Suncoast Credit Union Arena in Fort Myers, Florida. Siena (3-3), which lost its third straight, showed a glimmer of life by getting within 63-56 with 1:44 left, but the RedHawks (3-2) pulled away by making seven of eight free throws the rest of the way. “Really, for the first time, I was disgusted with how we played,” McNamara said. “Twenty-two points off turnovers. We didn’t make each other better. We settled for 3’s to start. “Every time we got ourselves in position, one or two possessions, we made a mistake, didn’t get an offensive rebound [for Miami] that led to a 3.” Particularly irksome to McNamara was a sequence with less than 8 1/2 minutes left in the game while Siena had gone to a zone defense. The RedHawks’ Kam Craft and Brant Byers missed back-to-back 3-pointers on the possession, but the Saints couldn’t get the rebound in either case, and Kam Craft, Miami’s leading scorer and a high-volume shooter from behind the arc, made the Saints pay with a 3 for a 51-42 lead. Craft finished with 18 points and actually managed to drop his season 3-point percentage to a still-stellar .452 by going 5-for-13. “The zone was good for awhile, but of the six or seven 3-pointers they took, two of them came off offensive rebounds, free possessions,” McNamara said. “So, really, I’m pretty disgusted with how we played.” Marcus Freeman led Siena with 15 points, but was 6 for 18 from the field, Brendan Coyle and Justice Shoats each scored 12 points and Reid Ducharme scored 10. Peter Suder also scored 18 for the RedHawks, and had the hot hand early before Craft picked up the slack later. Miami got the upper hand early with a 12-0 run to take a 16-4 lead, at which point Suder had nine points. The Saints played catch-up the rest of the way, with no success. “We didn’t play well,” Coyle said. “It was a sloppy game for us. We fought back towards the end, but we couldn’t get over that hump. We’ve just got to flush this one out and get ready for our next opponent.” “We’ll be ready. We’re going to be ready to compete,” McNamara said. “We’re going to watch most all of this. We’ll cut it up, and we can show them how gross it was. We’ll prepare them the best we can on short notice.” Siena will play Jacksonville at 11 a.m. on Tuesday to determine third place in the Tip-Off Palms Division. The Dolphins lost to Mercer 90-89 in overtime in Monday’s other semifinal. The Saints’ struggles to score on the fast break continued, with just two points. Out of 355 NCAA Division I men’s programs, Siena ranked 355th (2.20 fast break points per game) heading into the Miami game.CHARLESTON, S.C. (AP) — Bryce Thompson scored 17 points, Marchelus Avery had 15 points and eight rebounds, and Oklahoma State beat Miami 80-74 on Friday in the consolation bracket of the Charleston Classic. Oklahoma State (4-1) will play in the fifth-place game on Sunday, while Miami (3-2) will try to avoid going winless in the tournament. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get any of our free email newsletters — news headlines, obituaries, sports, and more.

Stock Market Today: Wall Street Holds Near Breakeven Ahead of Christmas

Iran, China Share Views on Mideast Developments